首页 | 本学科首页   官方微博 | 高级检索  
     

血清细胞角蛋白19在预测进展期非小细胞肺癌患者化疗疗效及预后中的临床意义
引用本文:Xu C,Liu J,Xing L,Liu S. 血清细胞角蛋白19在预测进展期非小细胞肺癌患者化疗疗效及预后中的临床意义[J]. 中国肺癌杂志, 2010, 13(10): 954-961. DOI: 10.3779/j.issn.1009-3419.2010.10.05
作者姓名:Xu C  Liu J  Xing L  Liu S
作者单位:中国医科大学附属第四医院肿瘤内科,沈阳,110032
摘    要:背景与目的由于RECIST(Response Evaluation Criteria in Solid Tumors, RECIST)标准不能对存活肿瘤组织进行检测,也不能对所有无法测量病灶的非小细胞肺癌(non-small cell lung cancer, NSCLC)患者的疗效进行准确评估,本研究通过检测进展期NSCLC患者化疗前后血清细胞角蛋白19片段(cytokeratin 19 fragment, CYFRA21-1) 表达水平的变化以评价其在预测进展期NSCLC患者化疗疗效及预后中的临床价值。方法采用全自动生化分析仪电化学发光免疫法检测112例初治的NSCLC患者化疗前和化疗2周期后血清CYFRA21-1表达水平的变化,应用受试者特征工作曲线(receiver operating characteristics curve, ROC)评价血清CYFRA21-1反应在诊断影像学缓解(objective response, OR)中的效能及其与预后的相关性。结果经一线铂类为基础的两药联合方案化疗2周期后,血清CYFRA21-1水平较化疗前基线水平明显下降。80例可评价影像学和血清学疗效的患者中,26...

关 键 词:细胞角蛋白19片段  肺肿瘤  化疗疗效  影像学缓解  预测因素  预后因素  

Clinical significance of serum cytokeratin 19 fragment in the prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer
Xu Chong'an,Liu Jiali,Xing Lili,Liu Shu. Clinical significance of serum cytokeratin 19 fragment in the prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer[J]. Chinese journal of lung cancer, 2010, 13(10): 954-961. DOI: 10.3779/j.issn.1009-3419.2010.10.05
Authors:Xu Chong'an  Liu Jiali  Xing Lili  Liu Shu
Affiliation:Department of Oncology Medicine, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China. cmu4h-xca@126.com
Abstract:Background and objective RECIST (Response Evaluation Criteria in Solid Tumors) criteria could not be used to detect viable tumor tissue and is not an accurate tool for evaluation of objective response (OR) in non-small cell lung cancer (NSCLC) patients without measurable lesions. The aim of this study is to detect the pre-and post-chemotherapy serum cytokeratin 19 fragment (CYFRA21-1) expression levels in advanced NSCLC patients to evaluate the clinical value of CYFRA21-1 in the prediction of chemotherapy r...
Keywords:CYFRA21-1  Lung neoplasms  Chemotherapy efficacy  Radiological response  Predictor factors  Prognostic factors  
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号